"Optimizing use of SGLT2 inhibitors and other evidence-based therapies to improve outcomes in patients with type 2 diabetes and chronic kidney disease: An opportunity for pharmacists." by Joshua J Neumiller

Selected Works of Katherine R. Tuttle, MD, FASN, FACP, FNKF

Article

Optimizing use of SGLT2 inhibitors and other evidence-based therapies to improve outcomes in patients with type 2 diabetes and chronic kidney disease: An opportunity for pharmacists.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Joshua J Neumiller, Providence St Joseph Health, Providence Medical Research Center, Spokane, Washington
Jay H Shubrook
Tom Manley
Radica Z Alicic, Providence Medical Research Center, Providence Health Care, Spokane, WA
Katherine R Tuttle, Providence Medical Research Center, Providence Health Care, Spokane, WA

Link

Document Type

Article

Publication Date

6-29-2021

Keywords

washington,
spokane

Disciplines

Area of Special Interest

Kidney & Diabetes

Specialty/Research Institute

Endocrinology

Specialty/Research Institute

Nephrology

Citation Information

Joshua J Neumiller, Jay H Shubrook, Tom Manley, Radica Z Alicic, et al.. "Optimizing use of SGLT2 inhibitors and other evidence-based therapies to improve outcomes in patients with type 2 diabetes and chronic kidney disease: An opportunity for pharmacists." American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists (2021)
Available at: http://works.bepress.com/katherine-tuttle/345/